Drug Profile
NPC 17730
Latest Information Update: 25 Aug 1997
Price :
$50
*
At a glance
- Originator Scios
- Class Analgesics; Antiallergics; Antiasthmatics; Antirheumatics
- Mechanism of Action Bradykinin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma; Pain; Rheumatic disorders; Septic shock
Most Recent Events
- 25 Aug 1997 No-Development-Reported for Asthma in USA (Unknown route)
- 25 Aug 1997 No-Development-Reported for Pain in USA (Unknown route)
- 25 Aug 1997 No-Development-Reported for Rheumatic disorders in USA (Unknown route)